Art. 23b Directive (EU) 2001/83

In forcesince 28 Jan 2019cited 11×
1.

Variations shall be classified in different categories depending on the level of risk to public health and the potential impact on the quality, safety and efficacy of the medicinal product concerned. Those categories shall range from changes to terms of the marketing authorisation that have the highest potential impact on the quality, safety or efficacy of the medicinal product, to changes that have no or minimal impact thereon.

2.

The procedures for examination of applications for variations shall be proportionate to the risk and impact involved. Those procedures shall range from procedures that allow implementation only after approval based on a complete scientific assessment to procedures that allow immediate implementation and subsequent notification by the marketing authorisation holder to the competent authority.

2a.

The Commission is empowered to adopt delegated acts in accordance with Article 121a in order to supplement this Directive by:

(a)

specifying the categories in which variations shall be classified; and

(b)

establishing procedures for the examination of applications for variations to the terms of marketing authorisations.

3.

When adopting the delegated acts referred to in this Article, the Commission shall endeavour to make possible the submission of a single application for one or more identical changes made to the terms of different marketing authorisations.

4.

A Member State may continue to apply national provisions on variations applicable at the time of entry into force of Commission Regulation (EC) No 1234/2008 [Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products (OJ L 334, 12.12.2008, p. 7).] to marketing authorisations granted before 1 January 1998 to medicinal products authorised only in that Member State. Where a medicinal product subject to national provisions in accordance with this Article is subsequently granted a marketing authorisation in another Member State, Regulation (EC) No 1234/2008 shall apply to that medicinal product from that date.

5.

Where a Member State decides to continue to apply national provisions pursuant to paragraph 4, it shall notify the Commission thereof. If a notification has not been made by 20 January 2011, Regulation (EC) No 1234/2008 shall apply.

The 10 that are cited most themselves, of 11.

  • Commission Regulation (EC) No 1234/2008 of 24 November 2008 concerning the examination o…24aLaw

    De medlemsstater, der i overensstemmelse med artikel 23b, stk. 4, i direktiv 2001/83, kan fortsætte med at anvende de nationale bestemmelser om ændringer på visse rent nationale markedsføringstilladelser, er opført i bilag VI til …

  • Regulation (EU) 2019/54Lawamends

    … 1234/2008 i henhold til artikel 23b, stk. 4 og 5, i direktiv 2001/83/EF.

  • Commission Regulation (EU) No 712/2012 of 3 August 2012 amending Regulation (EC) No 1234…1Law

    … 67.], and in particular Article 23b(1) thereof, Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal …

  • Directive (EU) 2017/15725Law

    … v registrační dokumentaci nutná změna, provede se tato změna prostřednictvím opatření zavedených v souladu s článkem 23b směrnice 2001/83/ES.

  • Arzneimittelbetriebsordnung 20094Law

    … (3) Ist eine Änderung an den Zulassungsunterlagen erforderlich, so hat dies nach Maßgabe der in Übereinstimmung mit Art. 23b der Richtlinie 2001/83/EG getroffenen Vorkehrung zu erfolgen.

  • Regulation (EU) 2021/756Law

    … 67.], and in particular Article 23b thereof, Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal …

  • Opinion of Advocate General Kokott delivered on 4 October 2018. Staat der Nederlanden v Warner-Lambert Company LLC.Decision

    Regulation No 1234/2008, which was adopted in particular on the basis of the original version of Article 35(1) of Directive 2001/83, [Only Article 23b of Directive 2001/83 now refers to the adoption of an implementing regulation.] …

    4 Oct 2018 · 62017CC0423

  • Regulation (EU) 2024/1701Law

    … 67, ELI: http://data.europa.eu/eli/dir/2001/83/oj.], and in particular Article 23b(2a) thereof, Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for …

  • Regulation (EU) 2026/863Law

    … 67, ELI: http://data.europa.eu/eli/dir/2001/83/oj.], and in particular Article 23b(2a) thereof, Having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for …

  • Regulation (EU) 2019/5 of the European Parliament and of the Council of 11 December 2018…4Law

    … 726/2004 and Directive 2001/83/EC and that are not excluded from the scope of Regulation (EC) No 1234/2008 pursuant to Article 23b(4) and (5) of Directive 2001/83/EC.